SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)

首页> 外文期刊>Cancer letters >SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)

【24h】

SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)

机译：SOMCL-863，一种新颖，选择性和口服生物可利用的小分子C-Met抑制剂，在体外和体内展示抗肿瘤活性（Vol 351，PG 413,2014）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer letters》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014) [J] . Cancer letters . 2020,第期

机译：SOMCL-863，一种新颖，选择性和口服生物可利用的小分子C-Met抑制剂，在体外和体内展示抗肿瘤活性（Vol 351，PG 413,2014）
2. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo [J] . Meng-yuan LI, Yong-cong LV, Lin-jiang TONG, 中国药理学报：英文版 . 2016,第003期

机译：DW10075是一种新型的VEGFR选择性小分子抑制剂，在体内和体外均具有抗肿瘤活性
3. Abstract 408: ACP-196, An Orally Bioavailable Covalent Selective Inhibitor of Btk, Modulates the Innate Tumor Microenvironment, Exhibits Antitumor Efficacy and Enhances Gemcitabine Activity in Pancreatic Cancer (Retraction of Vol 75, Pg 18, 2015) [J] . Cancer research: The official organ of the American Association for Cancer Research, Inc . 2017,第17期

机译：摘要408：ACP-196，BTK的口服生物可利用的共价选择性抑制剂调节先天肿瘤微环境，表现出抗肿瘤疗效，增强胰腺癌中的吉西他滨活性（R-75，PG 18,2015的收缩）
4. CNX-774, an Irreversible, Selective and Orally Bioavailable Inhibitor of Bruton's Tyrosine Kinase: In Vitro ADME, Selectivity, and Pharmacokinetic Properties [C] . Prasoon Chaturvedi, Matthew Labenski, Erica Evans, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：CNX-774，Bruton的酪氨酸激酶的不可逆转，选择性和口服生物可利用的抑制剂：体外Adme，选择性和药代动力学性能
5. Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1. [D] . Wang, Yijun. 2016

机译：噻唑-缬氨酸肽模拟物（TTT-28）通过选择性抑制ABCB1的外排活性，在体外和体内拮抗多药耐药性。
6. DW10075 a novel selective and small-molecule inhibitor of VEGFR exhibits antitumor activities both in vitro and in vivo [O] . Meng-yuan Li, Yong-cong Lv, Lin-jiang Tong, 2016

机译：DW10075是新型的VEGFR选择性小分子抑制剂在体内和体外均具有抗肿瘤活性
7. AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity [O] . Christine M. Chresta, Barry R. Davies, Ian Hickson, 2009

机译：AZD8055是具有体外和体内抗肿瘤活性的有效，选择性和口服生物利用的ATP竞争性哺乳动物靶标催选酶抑制剂

SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)

著录项

相似文献

相关主题

期刊订阅